Evidence map›Paper›PMID 22264607›Full record

ArticleCurrent biology : CB2012

Myosin IIIB uses an actin-binding motif in its espin-1 cargo to reach the tips of actin protrusions.

Raymond C Merritt, Uri Manor, Felipe T Salles, M'hamed Grati, Andrea C Dose, William C Unrath, Omar A Quintero, Christopher M Yengo, Bechara Kachar

Open access · bronzeAbstract read
In one paragraph

Article in Current biology : CB, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 69 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Liquid-liquid phase separation in hair cell stereocilia development and maintenance.Computational and structural biotechnology journal · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. E3 ubiquitin ligase ASB17 is required for spermiation in mice.Translational andrology and urology · 2021
    Article
  18. Article
  19. Review
  20. Functional Role of Class III Myosins in Hair Cells.Frontiers in cell and developmental biology · 2021
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Raymond C MerrittLaboratory of Cell Structure and Dynamics, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD 20892, USA.
Uri Manor
Felipe T Salles
M'hamed Grati
Andrea C Dose
William C Unrath
Omar A Quintero
Christopher M Yengo
Bechara Kachar
National Institutes of Health · USPennsylvania State University · USGallaudet University · USNational Institute on Deafness and Other Communication Disorders · USUniversity of California, Berkeley · US

Funding

Structural and Molecular Basis of Transduction in Auditory Sensory OrgansZIADC000002 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI KACHAR, BECHARA · 2009 to 2025
$38.3M
Molecular organization of intercellular junctions in the inner earZIADC000009 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI KACHAR, BECHARA · 2012 to 2020
$5.5M
MOLECULAR BASIS OF TRANSDUCTION IN AUDITORY SENSORY ORGANSZ01DC000002 · NIDCD · NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS · PI KACHAR, BECHARA · 1989 to 2008
$3.9M
Enzymatic and Motor Properties of Myosin IIIR01EY018141 · NEI · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI YENGO, CHRISTOPHER M · 2008 to 2012
$1.3M
Energy Transduction in MyosinR21HL093531 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHARLOTTE · PI YENGO, CHRISTOPHER M · 2009 to 2010
$390k
Enzymatic and Motor Properties of Myosin 19K01CA160667 · NCI · UNIVERSITY OF RICHMOND · PI QUINTERO-CARMONA, OMAR ALBERTO · 2011 to 2013
$353k
Intramural NIH HHS Z01 DC000002Intramural NIH HHS ZIA DC000002NCI NIH HHS K01 CA160667NEI NIH HHS EY018141NEI NIH HHS R01 EY018141NHLBI NIH HHS HL093531NHLBI NIH HHS R21 HL093531NIDCD NIH HHS Z01-DC000002-22
6 · The paper itself

Abstract

Myosin IIIA (MYO3A) targets actin protrusion tips using a motility mechanism dependent on both motor and tail actin-binding activity [1]. We show that myosin IIIB (MYO3B) lacks tail actin-binding activity and is unable to target COS7 cell filopodia tips, yet is somehow able to target stereocilia tips. Strikingly, when MYO3B is coexpressed with espin-1 (ESPN1), a MYO3A cargo protein endogenously expressed in stereocilia [2], MYO3B targets and carries ESPN1 to COS7 filopodia tips. We show that this tip localization is lost when we remove the ESPN1 C terminus actin-binding site. We also demonstrate that, like MYO3A [2], MYO3B can elongate filopodia by transporting ESPN1 to the polymerizing end of actin filaments. The mutual dependence of MYO3B and ESPN1 for tip localization reveals a novel mechanism for the cell to regulate myosin tip localization via a reciprocal relationship with cargo that directly participates in actin binding for motility. Our results are consistent with a novel form of motility for class III myosins that requires both motor and tail domain actin-binding activity and show that the actin-binding tail can be replaced by actin-binding cargo. This study also provides a framework to better understand the late-onset hearing loss phenotype in patients with MYO3A mutations.

Indexed as

Actin CytoskeletonActinsAmino Acid MotifsAnimalsChlorocebus aethiopsCOS CellsHumansMiceMicrofilament ProteinsMicroscopy, ConfocalMicroscopy, FluorescenceMyosin Heavy ChainsMyosin Type IIIPolymerase Chain ReactionProtein BindingProtein TransportActinsespin protein, mouseMicrofilament ProteinsMYO3A protein, mouseMYO3B protein, mouseMyosin Heavy ChainsMyosin Type III

Identifiers

PMID22264607
PMCPMC3288355
OpenAlexW2122163415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.